Literature DB >> 22386411

High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma.

Jeffrey K Wang1, Matthew K Tollefson, Amy E Krambeck, Landon W Trost, R Houston Thompson.   

Abstract

OBJECTIVE: To determine the association between endoscopic biopsy grade and the final pathologic characteristics at nephroureterectomy for upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is an important tool for patients with UTUC because the results can influence the management decisions.
METHODS: We identified 481 patients who had undergone nephroureterectomy for UTUC at the Mayo Clinic from 1995 to 2008. Of these patients, 184 underwent endoscopic cup or brush biopsy before nephroureterectomy. The biopsy tumor grade was then compared with the tumor grade and stage obtained at nephroureterectomy.
RESULTS: Of the 184 patients, 27 (15%) had nondiagnostic biopsy results and 21 (11%) had positive biopsy results with no histologic grade. Of the 24 patients with grade 1 tumors on biopsy, 23 (96%) had the tumor upgraded on the final pathologic examination: 16 (67%) to grade 2 and 7 (29%) to grade 3. Similarly, 23 (40%) of 57 grade 2 tumors on biopsy were upgraded to grade 3 after nephrouretecomy. Only a few patients, 7 (4%) of 184, were found to have a lower histologic grade on the final pathologic examination. The number of patients with invasive UTUC for endoscopic grade 1, 2, and 3 tumors was 9 (38%) of 24, 31 (54%) of 57, and 47 (85%) of 55, respectively.
CONCLUSION: In the context of patients selected for nephroureterectomy, we observed a greater than expected rate of tumor upgrading and invasive disease, particularly in those with low-grade tumors at biopsy. These findings should be considered when electing to use conservative or endoscopic management of low-grade UTUC. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22386411     DOI: 10.1016/j.urology.2011.11.049

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  Reflections on personalized management of UTUC.

Authors:  Marianne Brehmer
Journal:  World J Urol       Date:  2018-02-19       Impact factor: 4.226

2.  Conservative treatment of upper urinary tract carcinoma: Long-term results.

Authors:  Andrea Orosa Andrada; Inés Laso García; Fernando Arias Fúnez; Francisco Donis Canet; Gemma Duque Ruiz; Victoria Gómez Dos Santos; Francisco Javier Burgos Revilla
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

Review 3.  Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.

Authors:  Harun Fajkovic; Tobias Klatte; Udo Nagele; Michael Dunzinger; Richard Zigeuner; Wilhelm Hübner; Mesut Remzi
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

4.  Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.

Authors:  Michael Baboudjian; Khalid Al-Balushi; Floriane Michel; Francois Lannes; Akram Akiki; Sarah Gaillet; Veronique Delaporte; Evelyne Ragni; Harry Toledano; Gilles Karsenty; Dominique Rossi; Cyrille Bastide; Eric Lechevallier; Romain Boissier
Journal:  World J Urol       Date:  2019-04-16       Impact factor: 4.226

5.  Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma.

Authors:  Jose A Pedrosa; Timothy A Masterson; Kevin R Rice; Hristos Z Kaimakliotis; M Francesca Monn; Richard Bihrle; Michael O Koch; Ronald S Boris
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

6.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 7.  Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?

Authors:  Stephanie P Chen; Joseph C Liao
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

8.  A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.

Authors:  Daniel Bui; Kathleen E Mach; Dimitar V Zlatev; Robert V Rouse; John T Leppert; Joseph C Liao
Journal:  J Endourol       Date:  2015-10-06       Impact factor: 2.942

Review 9.  Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma.

Authors:  Victor M Schuettfort; Benjamin Pradere; Fahad Quhal; Hadi Mostafaei; Ekaterina Laukhtina; Keiichiro Mori; Reza Sari Motlagh; Michael Rink; David D'Andrea; Mohammad Abufaraj; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Turk J Urol       Date:  2020-10-09

10.  Ex-vivo study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasound.

Authors:  Mieke T J Bus; Paul Cernohorsky; Daniel M de Bruin; Sybren L Meijer; Geert J Streekstra; Dirk J Faber; Guido M Kamphuis; Patricia J Zondervan; Marcel van Herk; Maria P Laguna Pes; Maik J Grundeken; Martin J Brandt; Theo M de Reijke; Jean J M C H de la Rosette; Ton G van Leeuwen
Journal:  J Med Imaging (Bellingham)       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.